dabigatran has been researched along with Brain Hemorrhage, Cerebral in 68 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 62 (91.18) | 24.3611 |
| 2020's | 6 (8.82) | 2.80 |
| Authors | Studies |
|---|---|
| Del Zoppo, GJ; Gu, YH; Hawkins, BT; Izawa, Y; Koziol, JA; Yoshikawa, Y | 1 |
| Cho, MS; Choi, KJ; Kang, DH; Kim, DH; Kim, J; Kim, M; Kim, SJ; Lee, S; Lee, SA; Nam, GB; Song, JM | 1 |
| Arioli, D; Athanasiou, A; Ballestri, S; Capitelli, M; Cappi, C; Coluccio, V; Di Girolamo, M; Marietta, M; Marrazzo, A; Romagnoli, E | 1 |
| Kuramatsu, JB; Sembill, JA | 1 |
| Goyal, N; Mowla, A; Sadighi, A; Seiffge, DJ; Shahjouei, S; Tsivgoulis, G; Wang, M; Zand, R | 1 |
| Moullaali, TJ; Parry-Jones, AR; Ziai, WC | 1 |
| Barnes, GD; Cuker, A; Dawwas, GK; Dietrich, E; Leonard, CE; Lewis, JD | 1 |
| Adachi, T; Fujioka, S; Hoshino, H; Takagi, M | 1 |
| Gotoh, S; Kuwashiro, T; Nakamura, A; Nakanishi, Y; Okada, Y; Takaguchi, G; Tomoda, M; Yasaka, M | 1 |
| Benavente, O; Butcher, K; Coutts, SB; Field, TS; Gioia, L; Hill, MD; Ng, KH; Sharma, M | 1 |
| Alberts, MJ; Bunz, TJ; Coleman, CI; Peacock, WF | 1 |
| Boulouis, G; Charidimou, A; Goldstein, JN; Gurol, ME; Morotti, A; Pasi, M | 1 |
| Chaturvedi, S; Diener, HC; Hohnloser, SH; Molina, CA; Selim, MH | 1 |
| Fuh, L; Goldstein, JN; Hayes, BD; Sin, JH | 1 |
| Haas, K; Heuschmann, PU; Khan, S; Purrucker, JC; Rizos, T; Siedler, T; Veltkamp, R; Wolf, M | 1 |
| Černík, D; Herzig, R; Jakubíček, S; Kunáš, Z; Mikulík, R; Ostrý, S; Reif, M; Rohan, V; Šaňák, D; Tomek, A; Veverka, T | 1 |
| Bereczki, D; Kakuk, I; May, Z; Szakács, Z; Szilágyi, G | 1 |
| Eichler, H; Hummel, BA; Schleicher, C; Senger, S | 1 |
| Bakkehøi, G; Eek, AK; Stenberg-Nilsen, H; Strøm, BO | 1 |
| Eto, A; Hiraoka, F; Nii, K; Tsutsumi, M | 1 |
| Chen, CL; Chen, HM; Chen, LA; Chen, PL; Chou, PC; Fang, CW; Hsieh, CY; Li, YH; Lu, CM; Shih, YS; Sun, MC; Tsai, YT; Tsao, CR; Yeh, JT | 1 |
| Bae, HJ; Chung, I; Gwak, DS; Han, MK; Kang, JH; Kim, BJ; Kim, BK; Woo, HG | 1 |
| Arbel, M; Ayata, C; Bacskai, BJ; Böhm, M; Boulouis, G; Endres, M; Fischer, P; Frosch, MP; Greenberg, SM; Qin, T; Schlunk, F; Tamim, I | 1 |
| Carrier, M; Ho, ML | 1 |
| Ploen, R; Sun, L; Veltkamp, R; Zhou, W; Zorn, M | 1 |
| Bauer, KA | 1 |
| Dinkel, J; Foerch, C; Gupta, R; Hayakawa, K; Karatas, H; Lauer, A; Leung, W; Lo, EH; Schlunk, F; Steinmetz, H; Won, SY | 1 |
| Damgaard, D; Simonsen, CZ; Steiner, T; Tietze, A | 1 |
| Okada, Y; Yasaka, M | 2 |
| Laroche, JP | 1 |
| Hanon, O | 1 |
| Faust, AC; Peterson, EJ | 1 |
| Foerch, C; Lauer, A; Leung, W; Lo, EH; Lok, J; Schaefer, JH; Van Cott, EM; van Leyen, K; van Ryn, J; Whalen, M; Wu, L | 1 |
| Hess, T; Konturek, P | 1 |
| Berthold, C; Boecher-Schwarz, H; Dooms, G; Gunness, VR; Hana, A; Hertel, F; Koy, J; Matgé, G; Standhardt, H | 1 |
| Ammollo, CT; Colucci, M; Semeraro, N; Testa, S; Visino, F; Zaccaria, F | 1 |
| Hirose, Y; Inamasu, J; Tanoue, S; Toyama, H; Yamada, M | 1 |
| Bernier-Jean, A; Bouchard, J; Eris, JM; Ghannoum, M; Kershaw, G; Patel, JP; Roberts, DM; Tran, H; Weatherburn, C; Williamson, D | 1 |
| Bovi, P; Cappellari, M | 1 |
| Mracsko, E; Na, SY; van Ryn, J; Veltkamp, R | 1 |
| Collins, J; Fraeman, K; Reynolds, MW; Schnee, J; Schwartzman, E; Siu, K; Villines, TC | 1 |
| Bartels, DB; Bykov, K; Huybrechts, K; Schneeweiss, S; Seeger, JD; Zint, K | 1 |
| Yasaka, M | 1 |
| Åsberg, S; Hijazi, Z; Norrving, B; Oldgren, J; Terent, A | 1 |
| Einecke, D | 1 |
| Pollack, CV | 1 |
| Dittmeier, M; Fluri, F; Kleinschnitz, C; Kraft, P; Schuhmann, MK; Wassmuth, K | 1 |
| Abe, H; Aizawa, Y; Fujii, Y; Jimbo, Y; Sato, M; Takahashi, H; Takano, H | 1 |
| Abraham, NS; McBane, RD; Noseworthy, PA; Sangaralingham, LR; Shah, ND; Yao, X | 1 |
| Biagi, C; Conti, V; Donati, M; Melis, M; Monaco, L; Motola, D; Vaccheri, A; Venegoni, M | 1 |
| Clemens, A; Feuring, M; Haertter, S; Liesenfeld, KH; Stangier, J; van Ryn, J; Wienen, W | 1 |
| Chan, L | 1 |
| Michota, F | 1 |
| Qureshi, AI; Siddiqui, FM; Watanabe, M | 1 |
| Cianchetti, FA; Foerch, C; Lauer, A; Lo, EH; Pfeilschifter, W; Schaffer, CB; Schlunk, F; Schulz, E; Steinmetz, H; Van Cott, EM | 1 |
| Bendszus, M; Heiland, S; Illanes, S; Liesz, A; Middelhoff, M; Schwarting, S; van Ryn, J; Veltkamp, R; Zhou, W; Zorn, M | 1 |
| Calle Escobar, ML; Casado Naranjo, I; Jiménez Caballero, PE; Portilla-Cuenca, JC; Romero Sevilla, RM | 1 |
| Dempfle, CE; Hennerici, MG | 1 |
| Diener, HC; Eikelboom, J; Granger, CB; Hacke, W | 1 |
| Baumgarten, P; Bohmann, F; Foerch, C; Lindhoff-Last, E; Mittelbronn, M; Pfeilschifter, J; Pfeilschifter, W; Steinmetz, H | 1 |
| Brouns, R; De Keyser, J; De Raedt, S; De Smedt, A; Jochmans, K; Luijckx, GJ; Moens, M; Uyttenboogaart, M; Van Hooff, RJ | 1 |
| Kowey, PR; Naccarelli, GV | 1 |
| Fugate, JE; Lanzino, G; McBane, RD; Rabinstein, AA | 1 |
| Diener, HC; Harenberg, J; Lip, GY; Marder, VJ; Marx, S; Wehling, M; Weiss, C | 1 |
| Bohmann, F; Foerch, C; Lindhoff-Last, E; Mirceska, A; Pfeilschifter, J; Pfeilschifter, W; Steinmetz, H | 1 |
| Gliem, M; Hartung, HP; Hermsen, D; Jander, S; van Rooijen, N | 1 |
| Grove, EL; Husted, SE; Kraglund, KL; Modrau, B | 1 |
18 review(s) available for dabigatran and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative Review.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Gastrointestinal Hemorrhage; Humans; Rivaroxaban; Stroke; Venous Thromboembolism | 2023 |
[Acute treatment of intracerebral hemorrhage].
Topics: Anticoagulants; Antihypertensive Agents; Blood Coagulation Factors; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Hematoma; Humans | 2019 |
Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants: A Systematic Review and Meta-Analysis.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Female; Humans; Male; Middle Aged; Risk Factors; Stroke; Warfarin | 2020 |
Outcome of intracerebral haemorrhage related to non-vitamin K antagonists oral anticoagulants versus vitamin K antagonists: a comprehensive systematic review and meta-analysis.
Topics: Anticoagulants; Antithrombins; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Hematoma; Humans; Mortality; Odds Ratio; Phenprocoumon; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Severity of Illness Index; Thiazoles; Vitamin K; Warfarin | 2018 |
Reversal of Oral Anticoagulants for Intracerebral Hemorrhage Patients: Best Strategies.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Factors; Cerebral Hemorrhage; Dabigatran; Humans; Vitamin K | 2017 |
Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Humans; Monitoring, Physiologic; Morpholines; Prodrugs; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiophenes; Thrombin; Thromboembolism; Vitamin K; Warfarin | 2013 |
[Novel oral anticoagulants and atrial fibrillation in the elderly].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Drugs, Investigational; Half-Life; Humans; Intracranial Embolism; Metabolic Clearance Rate; Morpholines; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Vitamin K | 2013 |
[Gastrointestinal bleeding under treatment with new oral anticoagulants].
Topics: Administration, Oral; Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Gastrointestinal Hemorrhage; Humans; Intracranial Embolism; Morpholines; Postoperative Complications; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Thiophenes; Thrombosis; Vitamin K; Warfarin | 2014 |
NOAC and intracerebral bleeding--presentation of four cases and review of the literature.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Female; Humans; Hypertension; Male; Morpholines; Rivaroxaban; Thiophenes | 2014 |
Intravenous thrombolysis for stroke in patients taking non-VKA oral anticoagulants: an update.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cerebral Hemorrhage; Contraindications; Dabigatran; Drug Administration Schedule; Drug Interactions; Endovascular Procedures; Factor Xa Inhibitors; Female; Humans; Infusions, Intravenous; Kidney Function Tests; Male; Middle Aged; Practice Guidelines as Topic; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thrombectomy; Thrombolytic Therapy; Tissue Plasminogen Activator | 2015 |
New Insights into Nonvitamin K Antagonist Oral Anticoagulants' Reversal of Intracerebral Hemorrhage.
Topics: Animals; Anticoagulants; Blood Coagulation Factors; Cerebral Hemorrhage; Dabigatran; Humans; Stroke | 2015 |
Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity.
Topics: Administration, Oral; Anticoagulants; Benzimidazoles; Blood Coagulation; Cerebral Hemorrhage; Charcoal; Dabigatran; Drug Overdose; Humans; International Normalized Ratio; Pyridines; Sensitivity and Specificity; Thrombin; Thrombin Time; Treatment Outcome; Venous Thromboembolism | 2010 |
Intracerebral hemorrhage: Pick your poison.
Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Chronic Disease; Dabigatran; Humans; Pyrazoles; Pyridones; Recurrence; Risk Assessment; Venous Thromboembolism; Warfarin | 2010 |
Incidence and management of ischemic stroke and intracerebral hemorrhage in patients on dabigatran etexilate treatment.
Topics: Benzimidazoles; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Humans; Incidence; Pyridines; Stroke; Thrombin | 2012 |
Acute stroke management in patients taking dabigatran.
Topics: Anticoagulants; Benzimidazoles; Blood Coagulation Disorders; Case Management; Cerebral Hemorrhage; Cerebral Infarction; Dabigatran; Guidelines as Topic; Hemostasis; Hemostatics; Humans; Off-Label Use; Pyridines; Renal Dialysis; Reperfusion; Stroke; Vitamin K | 2012 |
Dabigatran: a primer for neurosurgeons.
Topics: Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Cerebral Hemorrhage; Dabigatran; Humans; Neurosurgery; Perioperative Care; Postoperative Complications | 2013 |
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Chi-Square Distribution; Dabigatran; Embolism; Female; Humans; Male; Middle Aged; Morpholines; Myocardial Infarction; Odds Ratio; Pyrazoles; Pyridones; Risk Assessment; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome | 2012 |
[Anticoagulant therapy in stroke patients].
Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Female; Humans; Male; Morpholines; Pyrazoles; Pyridones; Radiography; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thiophenes; Thromboembolism; Vitamin K | 2013 |
2 trial(s) available for dabigatran and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
Comparison of Dabigatran Versus Warfarin Treatment for Prevention of New Cerebral Lesions in Valvular Atrial Fibrillation.
Topics: Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Heart Valve Diseases; Humans; Stroke; Treatment Outcome; Warfarin | 2022 |
Dabigatran following acute transient ischemic attack and minor stroke II (DATAS II).
Topics: Administration, Oral; Antithrombins; Cerebral Hemorrhage; Dabigatran; Female; Humans; Ischemic Attack, Transient; Magnetic Resonance Imaging; Male; Recurrence; Sample Size; Stroke; Treatment Outcome | 2017 |
48 other study(ies) available for dabigatran and Brain Hemorrhage, Cerebral
| Article | Year |
|---|---|
Intracerebral hemorrhage and thrombin-induced alterations in cerebral microvessel matrix.
Topics: Animals; Anticoagulants; Benzimidazoles; Cerebral Hemorrhage; Dabigatran; Mice; Microvessels; Thrombin | 2022 |
Treatment of intracerebral hemorrhage: From specific interventions to bundles of care.
Topics: Administration, Oral; Anticoagulants; Cerebral Hemorrhage; Dabigatran; Hematoma; Humans; Stroke | 2020 |
Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Comparative Effectiveness Research; Dabigatran; Embolism; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Ischemic Stroke; Male; Propensity Score; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Treatment Outcome; Warfarin | 2021 |
Volume and Characteristics of Intracerebral Hemorrhage with Direct Oral Anticoagulants in Comparison with Warfarin
.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Blood Coagulation; Cerebral Hemorrhage; Chi-Square Distribution; Cross-Sectional Studies; Dabigatran; Disability Evaluation; Factor Xa Inhibitors; Female; Hematoma; Humans; Japan; Linear Models; Male; Middle Aged; Multivariate Analysis; Patient Discharge; Prospective Studies; Pyrazoles; Pyridones; Registries; Risk Factors; Rivaroxaban; Tomography, X-Ray Computed; Treatment Outcome; Warfarin | 2017 |
[Measurement of Prothrombin Fragment 1+2 for the Assessment of Anticoagulant Activity in Patients Treated with Warfarin or Non-vitamin K Antagonist Oral Anticoagulant].
Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Female; Humans; Male; Peptide Fragments; Prothrombin; Rivaroxaban; Warfarin | 2017 |
Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
Topics: Adolescent; Adult; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Cerebral Hemorrhage; Cohort Studies; Dabigatran; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Ischemic Attack, Transient; Male; Middle Aged; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Treatment Outcome; Warfarin; Young Adult | 2017 |
Off-Label Use of Direct Oral Anticoagulants in Intracerebral Hemorrhage Patients With Prosthetic Valves.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Humans; Male; Off-Label Use; Stroke; Warfarin | 2017 |
Microbleeds in ischemic vs hemorrhagic strokes on novel oral anticoagulants.
Topics: Aged; Aged, 80 and over; Anticoagulants; Cerebral Hemorrhage; Cerebral Small Vessel Diseases; Comorbidity; Dabigatran; Female; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Thrombolytic Therapy | 2018 |
Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
Topics: Administration, Intravenous; Aged; Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Female; Fibrinolytic Agents; Humans; Male; Recombinant Proteins; Retrospective Studies; Stroke; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2018 |
[Administration of idarucizumab in spontaneous intracerebral hemorrhage under dabigatran-therapy].
Topics: Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Cerebral Hemorrhage; Dabigatran; Humans | 2017 |
[The use of Idarucizumab in intracerebral bleeding - a case report].
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Atrial Fibrillation; Blood Coagulation Tests; Cerebral Hemorrhage; Dabigatran; Head Injuries, Closed; Hematoma, Subdural, Chronic; Humans; Male; Preoperative Care; Tomography, X-Ray Computed; Trephining | 2018 |
Anticoagulant-associated adverse drug reactions in 2013-15.
Topics: Age Distribution; Anticoagulants; Cerebral Hemorrhage; Comorbidity; Dabigatran; Databases, Factual; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Female; Hemorrhage; Humans; Male; Pyrazoles; Pyridones; Registries; Risk Factors; Rivaroxaban; Sex Distribution; Time Factors; Warfarin | 2018 |
[A Case of Successful Drug Management with Dabigatran and Idarucizumab to Address Embolic and Hemorrhagic Complications for Asymptomatic and Traumatic Subdural Hematoma with Non-valvular Atrial Fibrillation].
Topics: Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Embolism; Female; Hematoma, Subdural; Humans | 2018 |
Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antithrombins; Atrial Fibrillation; Blood Coagulation; Cerebral Hemorrhage; Dabigatran; Drug Administration Schedule; Feasibility Studies; Female; Fibrinolytic Agents; Humans; Infusions, Intravenous; Male; Middle Aged; Retrospective Studies; Risk Factors; Stroke; Taiwan; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2019 |
Intracerebral hemorrhage associated with warfarin versus non-vitamin K antagonist oral anticoagulants in Asian patients.
Topics: Administration, Oral; Aged; Anticoagulants; Asian People; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Female; Humans; Male; Middle Aged; Odds Ratio; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Warfarin; Young Adult | 2019 |
Secondary Bleeding During Acute Experimental Intracerebral Hemorrhage.
Topics: Acute Disease; Animals; Anticoagulants; Cerebral Hemorrhage; Dabigatran; Hemorrhage; Male; Mice; Random Allocation; Warfarin | 2019 |
Just the facts: Management of life-threatening bleeding with oral anticoagulant use in the emergency department.
Topics: Administration, Oral; Algorithms; Antibodies, Monoclonal, Humanized; Anticoagulants; Antifibrinolytic Agents; Cerebral Hemorrhage; Checklist; Clinical Decision-Making; Dabigatran; Drug Therapy, Combination; Emergency Service, Hospital; Female; Humans; Middle Aged; Tranexamic Acid | 2019 |
Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia.
Topics: Animals; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood-Brain Barrier; Cerebral Arteries; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Humans; Ischemia; Mice; Mice, Inbred C57BL; Rats; Stroke; Thrombolytic Therapy; Warfarin | 2013 |
Imaging of contrast medium extravasation in anticoagulation-associated intracerebral hemorrhage with dual-energy computed tomography.
Topics: Animals; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cerebral Hemorrhage; Contrast Media; Dabigatran; Iopamidol; Male; Mice; Radiography, Dual-Energy Scanned Projection; Time Factors; Warfarin | 2013 |
Dabigatran-related intracerebral hemorrhage resulting in hematoma expansion.
Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Fatal Outcome; Hematoma; Humans; Male; Risk Factors; Stroke; Time Factors; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
[Prevention and treatment of major bleeding during anticoagulation].
Topics: Administration, Oral; Alcohol Drinking; Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Diabetes Mellitus; Drug Therapy, Combination; Factor IX; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Risk Assessment; Risk Factors; Smoking; Vitamin K; Warfarin | 2013 |
[New anticoagulants: stop or more?].
Topics: Adverse Drug Reaction Reporting Systems; Anticoagulants; Antidotes; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Dissent and Disputes; Dose-Response Relationship, Drug; Drug Approval; Drug Industry; Drugs, Investigational; France; Humans; International Normalized Ratio; Lobbying; Pharmacovigilance; Thrombophilia | 2014 |
Management of dabigatran-associated intracerebral and intraventricular hemorrhage: a case report.
Topics: Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation Factors; Cerebral Hemorrhage; Dabigatran; Humans; Male | 2014 |
Translational insights into traumatic brain injury occurring during dabigatran or warfarin anticoagulation.
Topics: Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Factors; Brain; Brain Injuries; Cerebral Hemorrhage; Dabigatran; Hemorrhage; Mice; Mice, Inbred C57BL; Warfarin | 2014 |
Influence of cell-associated tissue factor concentration on the anticoagulant activity of dabigatran. A possible explanation for the reduced incidence of intracranial bleeding.
Topics: Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Case-Control Studies; Cerebral Hemorrhage; Dabigatran; Humans; Thromboplastin; Warfarin | 2015 |
Does dabigatran increase the risk of delayed hematoma expansion in a rat model of collagenase-induced intracerebral hemorrhage?
Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Collagenases; Dabigatran; Disease Models, Animal; Hematoma; Male; Rats; Rats, Wistar; Time Factors | 2015 |
Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran.
Topics: Aged; Aged, 80 and over; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Blood Coagulation Tests; Cerebral Hemorrhage; Dabigatran; Drug Monitoring; Fatal Outcome; Female; Half-Life; Hemorrhage; Humans; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Renal Replacement Therapy; Time Factors; Treatment Outcome | 2015 |
Idarucizumab Improves Outcome in Murine Brain Hemorrhage Related to Dabigatran.
Topics: Animals; Antibodies, Monoclonal, Humanized; Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Bleeding Time; Blood Coagulation; Brain; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Hematoma; Mice; Thrombin Time; Warfarin | 2015 |
A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Dabigatran; Databases, Factual; Disease-Free Survival; Drug Evaluation; Factor Xa Inhibitors; Female; Follow-Up Studies; Hemorrhage; Humans; Insurance Coverage; Kaplan-Meier Estimate; Male; Middle Aged; Military Personnel; Mortality; Myocardial Infarction; Propensity Score; Proportional Hazards Models; Retrospective Studies; Stroke; Thrombophilia; Treatment Outcome; Warfarin; Young Adult | 2015 |
Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Dabigatran; Databases, Factual; Drug Evaluation; Embolism; Factor Xa Inhibitors; Female; Follow-Up Studies; Hemorrhage; Hospitalization; Humans; Insurance Coverage; Male; Middle Aged; Myocardial Infarction; Polypharmacy; Propensity Score; Retrospective Studies; Stroke; Thrombophilia; Treatment Outcome; Warfarin; Young Adult | 2015 |
[Anticoagulants after acute ischemic stroke with atrial fibrillation].
Topics: Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Deglutition Disorders; Humans; Medical Records; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Rivaroxaban; Stroke; Time Factors; Time-to-Treatment; Treatment Outcome; Warfarin | 2016 |
[First new oral anticoagulant with specific antidote].
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Antidotes; Cerebral Hemorrhage; Dabigatran; Humans; Infusions, Intravenous; Stroke | 2016 |
Cardiology Patient Pages: Antidotes for Bleeding Caused by Novel Oral Anticoagulants.
Topics: Administration, Oral; Antibodies, Monoclonal, Humanized; Antithrombins; Blood Loss, Surgical; Cerebral Hemorrhage; Clinical Trials as Topic; Dabigatran; Drug Approval; Emergencies; Factor Xa; Factor Xa Inhibitors; Hemorrhage; Humans; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Thiazoles; United States; United States Food and Drug Administration | 2016 |
Dabigatran Etexilate Reduces Thrombin-Induced Inflammation and Thrombus Formation in Experimental Ischemic Stroke.
Topics: Animals; Anticoagulants; Blood Coagulation; Blood-Brain Barrier; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Inflammation; Male; Rats, Wistar; Stroke; Thrombin; Thrombosis | 2016 |
Intracerebral Hematoma Occurring During Warfarin Versus Non-Vitamin K Antagonist Oral Anticoagulant Therapy.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Brain; Case-Control Studies; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Female; Hematoma; Hospital Mortality; Humans; Male; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Tomography, X-Ray Computed; Warfarin | 2016 |
Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation.
Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Female; Humans; Male; Middle Aged; Propensity Score; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; United States | 2016 |
Safety profile of the direct oral anticoagulants: an analysis of the WHO database of adverse drug reactions.
Topics: Administration, Oral; Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticoagulants; Atrial Fibrillation; Cerebral Hemorrhage; Child; Child, Preschool; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Humans; Infant; Infant, Newborn; Male; Middle Aged; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stroke; Warfarin; World Health Organization; Young Adult | 2017 |
Will symptomatic intracerebral hemorrhages decrease among eligible dabigatran-treated patients who receive intravenous tissue plasminogen activator for acute ischemic stroke?
Topics: Benzimidazoles; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Humans; Pyridines; Stroke; Tissue Plasminogen Activator | 2010 |
Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.
Topics: Administration, Oral; Animals; Anticoagulants; Antithrombin Proteins; Benzimidazoles; Cerebral Hemorrhage; Collagenases; Dabigatran; Hematoma; Injections; Male; Mice; Mice, Inbred Strains; Microscopy, Fluorescence; Partial Thromboplastin Time; Pyridines; Time Factors; Warfarin | 2011 |
Hemostatic therapy in experimental intracerebral hemorrhage associated with the direct thrombin inhibitor dabigatran.
Topics: Animals; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Brain; Cerebral Hemorrhage; Dabigatran; Dose-Response Relationship, Drug; Mice | 2011 |
Fatal intracerebral hemorrhage associated with administration of recombinant tissue plasminogen activator in a stroke patient on treatment with dabigatran.
Topics: Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Cerebrovascular Circulation; Dabigatran; Electric Countershock; Fatal Outcome; Fibrinolytic Agents; Humans; Male; Middle Aged; Stroke; Tissue Plasminogen Activator; Tomography, X-Ray Computed | 2011 |
Fibrinolytic treatment of acute ischemic stroke for patients on new oral anticoagulant drugs.
Topics: Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Fibrinolytic Agents; Humans; Male; Stroke; Tissue Plasminogen Activator | 2011 |
The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War?
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Randomized Controlled Trials as Topic; Risk; Risk Factors; Stroke; Thrombin; Warfarin | 2012 |
Thrombolysis with recombinant tissue plasminogen activator under dabigatran anticoagulation in experimental stroke.
Topics: Animals; Anticoagulants; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Drug Interactions; Fibrinolytic Agents; Mice; Mice, Inbred C57BL; Stroke; Tissue Plasminogen Activator; Warfarin | 2012 |
The Food and Drug Administration decision not to approve the 110 mg dose of dabigatran: give us a way out.
Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Humans; Risk Assessment; Stroke; Thrombin; United States; United States Food and Drug Administration | 2012 |
No influence of dabigatran anticoagulation on hemorrhagic transformation in an experimental model of ischemic stroke.
Topics: Administration, Oral; Animals; Antithrombins; Benzimidazoles; beta-Alanine; Blood Coagulation; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Male; Mice; Pyridines; Stroke; Treatment Outcome | 2012 |
Secondary intracerebral hemorrhage due to early initiation of oral anticoagulation after ischemic stroke: an experimental study in mice.
Topics: Administration, Oral; Animals; Anticoagulants; Benzimidazoles; Blood Coagulation; Brain Ischemia; Cerebral Hemorrhage; Dabigatran; Disease Models, Animal; Intracranial Embolism; Macrophages; Male; Mice; Mice, Inbred C57BL; Phenprocoumon; Pyridines; Risk Factors; Stroke; Time Factors | 2012 |
[Management of intracranial hemorrhage during anticoagulant therapy with warfarin or novel anticoagulants].
Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Dabigatran; Humans; Intracranial Embolism; Morpholines; Rivaroxaban; Thiophenes; Warfarin | 2012 |